Scott Dahlbeck
Founder at KIROMIC BIOPHARMA, INC.
Net worth: 182 186 $ as of 30/05/2024
Scott Dahlbeck active positions
Companies | Position | Start | End |
---|---|---|---|
KIROMIC BIOPHARMA, INC. | Founder | 05/08/2006 | - |
Human Resources Officer | 08/02/2022 | - | |
Director/Board Member | 05/08/2006 | 30/09/2019 | |
Chief Tech/Sci/R&D Officer | 30/09/2019 | 08/02/2022 | |
President | 31/12/2012 | 30/09/2019 | |
Kiromic, Inc.
Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 31/12/2012 | - |
Founder | 31/12/2012 | - | |
President | 31/12/2012 | - |
Career history of Scott Dahlbeck
Training of Scott Dahlbeck
The University of Texas Health Science Center at Houston | Doctorate Degree |
University of Nebraska Medical Center | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
President | 2 |
Sectoral
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
KIROMIC BIOPHARMA, INC. | Health Technology |
Private companies | 1 |
---|---|
Kiromic, Inc.
Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Health Services |
- Stock Market
- Insiders
- Scott Dahlbeck
- Experience